Literature DB >> 2329826

Leukocyte depletion ameliorates free radical-mediated lung injury after cardiopulmonary bypass.

K Bando1, R Pillai, D E Cameron, J D Brawn, J A Winkelstein, G M Hutchins, B A Reitz, W A Baumgartner.   

Abstract

Activated leukocytes and oxygen free radicals have been implicated in the pathogenesis of lung injury associated with cardiopulmonary bypass. To determine whether leukocyte depletion could prevent this injury, we used a dog model simulating routine cardiac operations. Mongrel dogs (11 to 17 kg) were subjected to cardiopulmonary bypass with a bubble oxygenator and cooled to 27 degrees C. After aortic crossclamping and cardioplegic arrest for 90 minutes, control animals (n = 5) were rewarmed and weaned from bypass, and their condition was then stabilized for 90 minutes. Leukocyte-depleted animals (n = 5) had a leukocyte filter incorporated in the bypass circuit. During bypass, circulating leukocyte counts decreased by 60% in control dogs, and by 97% in leukocyte-depleted animals. Free radical generation (estimated by spectrophotometric assay of plasma conjugated dienes) was significantly reduced by leukocyte depletion during and after bypass. Total hemolytic complement activity and the titer of C5 decreased markedly immediately after the onset of bypass in both the control and leukocyte-depleted animals. Pulmonary function after bypass was better preserved in leukocyte-depleted animals. These data suggest that depletion of circulating leukocytes contributes to lung injury during cardiopulmonary bypass and is associated with increased oxygen radical activity, pulmonary edema, and vasoconstriction. Leukocyte depletion substantially reduced the pulmonary injury seen after cardiopulmonary bypass.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2329826

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  14 in total

1.  Evaluation of leukocyte-reducing arterial line filter (LG6) for postoperative lung function, using cardiopulmonary bypass.

Authors:  T Ohto; F Yamamoto; N Nakajima
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2000-05

2.  Kinetics of pro-inflammatory cytokines release in cardiac surgery with cardiopulmonary bypass.

Authors:  S Hirai; T Sueda; K Orihashi; M Watari; K Okada
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2001-04

3.  Relationship between respiratory distress and cytokine response after cardiopulmonary bypass.

Authors:  H Ito; K Hamano; H Gohra; T Katoh; Y Fujimura; H Tsuboi; K Esato
Journal:  Surg Today       Date:  1997       Impact factor: 2.549

4.  IL-6 and TNF alpha release in association with neutrophil activation after cardiopulmonary bypass surgery.

Authors:  R G Holzheimer; R G Molloy; H Görlach; S Wilkert; F Hehrlein
Journal:  Infection       Date:  1994 Jan-Feb       Impact factor: 3.553

5.  Prolonged granulocyte activation, as well as hypoxanthine and free radical production after open heart surgery in children.

Authors:  E J Pesonen; R Korpela; M Leijala; H Sairanen; O M Pitkänen; K O Raivio; P Venge; S Andersson
Journal:  Intensive Care Med       Date:  1996-05       Impact factor: 17.440

Review 6.  Leukodepletion for patients undergoing heart valve surgery.

Authors:  Sally Spencer; Augustine Tang; Espeed Khoshbin
Journal:  Cochrane Database Syst Rev       Date:  2013-07-31

7.  Effect of PAF on polyrnorphonuclear leucocyte plasma membrane polarity: a fluorescence study.

Authors:  A Kantar; P L Giorgi; R Fiorini
Journal:  Mediators Inflamm       Date:  1993       Impact factor: 4.711

8.  Aprotinin attenuates the elevation of pulmonary vascular resistance after cardiopulmonary bypass.

Authors:  Tae-Jin Yun; Joon-Ryang Rho
Journal:  J Korean Med Sci       Date:  2006-02       Impact factor: 2.153

Review 9.  Strategies to prevent intraoperative lung injury during cardiopulmonary bypass.

Authors:  Efstratios E Apostolakis; Efstratios N Koletsis; Nikolaos G Baikoussis; Stavros N Siminelakis; Georgios S Papadopoulos
Journal:  J Cardiothorac Surg       Date:  2010-01-11       Impact factor: 1.637

10.  NPC 15669 blocks neutrophil CD18 increase and lung injury during cardiopulmonary bypass in pigs.

Authors:  J M Bator; A M Gillinov; K J Zehr; J M Redmond; I C Wilson; A Herskowitz; J R Connor; R M Burch; D E Cameron
Journal:  Mediators Inflamm       Date:  1993       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.